135719-28-7 Usage
Description
Silicon phthalocyanine is a chemical compound belonging to the phthalocyanine family, characterized by the presence of a silicon atom at its core. It is renowned for its striking blue color and is valued for its exceptional thermal and chemical stability. This versatile compound finds applications in a variety of fields, including the production of dyes, pigments, semiconductors, electronic devices, photovoltaic cells, and inks. The high absorption of silicon phthalocyanine in the near-infrared region positions it as a potential candidate for medical imaging and photodynamic therapy. Furthermore, its unique chemical structure offers the flexibility to modify its properties, making it a promising material for future advancements in technology and material science.
Uses
Used in Dye and Pigment Industry:
Silicon phthalocyanine is utilized as a dye and pigment due to its vibrant blue color, providing a stable and long-lasting coloration for various applications.
Used in Semiconductor Industry:
In the semiconductor industry, silicon phthalocyanine serves as a material for electronic devices, capitalizing on its thermal and chemical stability to enhance device performance and reliability.
Used in Photovoltaic Cells:
Silicon phthalocyanine is employed in the development of photovoltaic cells, leveraging its high absorption in the near-infrared region to improve the efficiency of solar energy conversion.
Used in Ink Industry:
silicon phthalocyanine is used as an ink ingredient, offering a consistent and durable color for printing applications.
Used in Medical Imaging:
Silicon phthalocyanine is used as a contrast agent in medical imaging, taking advantage of its near-infrared absorption properties to enhance the visualization of internal structures.
Used in Photodynamic Therapy:
In the medical field, silicon phthalocyanine is applied in photodynamic therapy, where its light-absorbing properties are used to target and treat specific cells or tissues.
Used in Advanced Materials and Technologies:
Due to its unique chemical structure, silicon phthalocyanine is used as a base for the development of new materials and technologies, with its properties being modified to suit specific applications and innovations.
Check Digit Verification of cas no
The CAS Registry Mumber 135719-28-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,7,1 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 135719-28:
(8*1)+(7*3)+(6*5)+(5*7)+(4*1)+(3*9)+(2*2)+(1*8)=137
137 % 10 = 7
So 135719-28-7 is a valid CAS Registry Number.
InChI:InChI=1/C33H17N7.C7H18NOSi.H2O.Si/c1-3-11-20-18(9-1)26-17-27-19-10-2-4-12-21(19)29(35-27)37-31-23-14-6-8-16-25(23)33(39-31)40-32-24-15-7-5-13-22(24)30(38-32)36-28(20)34-26;1-8(2)6-5-7-10(3,4)9;;/h1-17H;5-7H2,1-4H3;1H2;/q-2;-1;;+4/p-1
135719-28-7Relevant articles and documents
Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy
Cheng, Yu,Doane, Tennyson L.,Chuang, Chi-Hung,Ziady, Assem,Burda, Clemens
, p. 1799 - 1804 (2014)
A photoprecursor Pc 227 is covalently bound onto gold nanoparticles (Au NPs) to produce the known photodynamic therapy (PDT) drug Pc 4 upon 660 nm photoirradiation. The photochemical formation of the photoproduct Pc 4 is identified by spectroscopy, chromatography, and mass spectrometry and its PDT efficacy is equal to Pc 4 when administered non-covalently by Au NPs, with the added benefit of improved covalent delivery and targeted NIR-triggered release from the covalent Pc 227-Au NP conjugate, while during transport the attached Pc 227 is quenched by the Au NP and PDT inactivated.
TOPICAL DELIVERY OF PHTHALOCYANINES
-
Page/Page column 20, (2008/06/13)
The invention relates to topical pharmaceutical compositions comprising a phthalocyanine, wherein a diamagnetic metal ion moiety is either coordinated or covalently bound to the phthalocyanine core. The invention also relates to methods for destroying cancer tissue, precancerous cells, photo-aged cells, damaged cells, or otherwise pathologic cells, or activated cells, such as lymphocytes or other cells of the immune system, or activated or inflamed tissue cells comprising topically administering to the cancer tissue or surrounding tissue an effective amount of a phthalocyanine composition.
